| Serum levels of VEGF and VEGF-C in patients with endometrial cancer. | |
| | |
MedLine Citation:
|
PMID: 21411409 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Endometrial cancer (EC) is the most common type of uterine cancer. A dualistic model of endometrial tumorigenesis serves as a useful way of categorizing these cancers in terms of both etiology and clinical behavior. There are two types of EC: type I and type II. Type I is so-called estrogen-dependent, and appears mostly in pre- and perimenopausal women, it is well differentiated and therefore has a better prognosis. Type II EC is estrogen-independent, diagnosed mostly in postmenopausal women, thin and fertile women, or in women with normal menstrual cycles. It is aggressive and has a worse prognosis than type I. The aim of this study was to evaluate the relationship between the pretreatment serum levels of VEGF and VEGF-C and the outcome of EC patients. A total of 98 patients treated between 1999 and 2003 were included in this study. Circulating VEGF and VEGF-C levels were determined using ELISA kits. VEGF levels among the 76 patients with type I, and the 22 patients with type II EC were significantly higher than those found in the healthy control subjects (p < 0.001). The differences in mean values of VEGF-C were highly significant in both types of tumor examined compared to the control (p < 0.001). The results demonstrate that serum VEGF concentration correlated significantly with advanced FIGO stage in type II EC (p < 0.001). The preoperative VEGF-C level correlated with advancing tumor stages in type I EC (p < 0.05). An elevated preoperative VEGF-C was an independent risk factor for disease-specific survival in patients with type II tumors. Thus, in type II EC patients with high preoperative levels of VEGF-C, pelvic and para-aortic lymphadenectomy should be performed. However, the value of longitudinal measurements of the markers used is yet to be determined. |
| | |
Authors:
|
Bozena Dobrzycka; Slawomir J Terlikowski; Oksana Kowalczuk; Marek Kulikowski; Jacek Niklinski |
Related Documents
:
|
23135679 - Evolution of a contagious cancer: epigenetic variation in devil facial tumour disease. 20211019 - Female partners of patients after surgical prostate cancer treatment: interactions with... 15305899 - How can experiences of patients and carers influence the clinical care of large bowel c... 23622249 - Punctuated evolution of prostate cancer genomes. 23210739 - Association of mdm2 and p53 polymorphisms with the advancement of cervical carcinoma. 21544409 - Cd44 with variant exons 8-10 in colorectal tumors. 8747379 - Perspective on cervical cancer: why prevent? 7150899 - Treatment of early localized breast cancer in elderly patients by tamoxifen. 20014199 - Exact tests using two correlated binomial variables in contemporary cancer clinical tri... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: European cytokine network Volume: 22 ISSN: 1952-4005 ISO Abbreviation: Eur. Cytokine Netw. Publication Date: 2011 Mar |
Date Detail:
|
Created Date: 2011-04-04 Completed Date: 2011-07-26 Revised Date: 2012-08-31 |
Medline Journal Info:
|
Nlm Unique ID: 9100879 Medline TA: Eur Cytokine Netw Country: France |
Other Details:
|
Languages: eng Pagination: 45-51 Citation Subset: IM |
Affiliation:
|
Department of Obstetrics, Gynecology and Obstetrics/Gynecological Care, Medical University of Bialystok, Poland. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Endometrial Neoplasms / blood*, surgery Female Humans Kaplan-Meier Estimate Middle Aged Neoplasm Staging Preoperative Care Vascular Endothelial Growth Factor A / blood* Vascular Endothelial Growth Factor C / blood* |
| Chemical | |
Reg. No./Substance:
|
0/VEGFA protein, human; 0/VEGFC protein, human; 0/Vascular Endothelial Growth Factor A; 0/Vascular Endothelial Growth Factor C |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Rate Control Scheme for Consistent Video Quality in Scalable Video Codec.
Next Document: Evaluation of new adipocytokines and insulin resistance in adolescents with polycystic ovary syndrom...